Memorial Sloan Kettering’s new tower on East 67th Street will be 76 feet shorter than previously planned, the cancer center ...

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

This article is authored by Dr Robin Mendelsohn, MD, gastroenterologist, Memorial Sloan Kettering Cancer Center.

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May ...

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, ...

CHICAGO -- Adding perioperative durvalumab (Imfinzi) to FLOT chemotherapy significantly improved event-free survival (EFS) ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Music therapy appeared as effective as first-line cognitive behavioral therapy for reduction of anxiety among cancer ...

NYC for MSK Participating Locations NYC for MSK 2025 Over 100 Participating Locations NEW YORK, NY, UNITED STATES, May 29, 20 ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...